524717 — Titan Biotech Share Price
0.000.00%
Last trade - 00:00- IN₹5.93bn
- IN₹5.98bn
- IN₹1.64bn
- 83
- 16
- 90
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.44 | ||
| Price to Tang. Book | 4.44 | ||
| Price to Free Cashflow | 406.83 | ||
| Price to Sales | 3.44 | ||
| EV to EBITDA | 17.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 22.6% | ||
| Return on Equity | 20.62% | ||
| Operating Margin | 18.01% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 794.38 | 1,422.37 | 1,235.49 | 1,439.99 | 1,640.72 | n/a | n/a | 20.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +85.18 | +362.76 | -29.08 | +14.57 | +0.04 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Titan Biotech Limited is an India-based company primarily engaged in the business of biological products. The Company is a manufacturer and exporter of the biological products used in the field of pharmaceuticals, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, microbiology, and others. The Company manufactures peptones, biological extracts, culture media and chemicals. It offers its products under various categories, such as Food Ingredients, Collagen and Proteins, Pharmaceuticals and Nutraceuticals, Animal Nutrition, Probiotics and Fermentation Ingredients, Agriculture Products, Culture Media and Natures Island. Its Food Ingredients include hydrolyzed vegetable protein (HVP), yeast extract powder, calcium propionate powder, potassium sorbate and calcium lactate. Its Collagen and Proteins include soya protein isolate, collagen peptides, chicken protein isolate, brown rice protein, and others.
Directors
- Charanjit Singh CCO
- Naresh Singla MDR (55)
- Suresh Singla MDR
- Manju Singla NED
- Rekha Dalmia IND
- Rohit Jain NID
- Ruchi Jain NID
- Praveen Somani NID
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- February 18th, 1992
- Public Since
- January 2nd, 1995
- No. of Shareholders
- 15,876
- No. of Employees
- 449
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 8,263,700
- Address
- 303-305 Lusa Tower, DELHI, 110034
- Web
- https://titanbiotechltd.com/
- Phone
- +91 1127355742
- Contact
- Charanjit Singh
- Auditors
- ANSK & Associates?
Upcoming Events for 524717
Similar to 524717
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Titan Biotech share price?
As of Today at 23:42 UTC, shares in Titan Biotech are trading at IN₹717.15. This share price information is delayed by 15 minutes.
How has the Titan Biotech share price performed this year?
Shares in Titan Biotech last closed at IN₹717.15 and the price had moved by +97.21% over the past 365 days. In terms of relative price strength the Titan Biotech share price has outperformed the S&P BSE 100 Index by +50.38% over the past year.
What are the analyst and broker recommendations for Titan Biotech?
There is no consensus recommendation for this security.
Find out moreWhat is the Titan Biotech dividend yield?
The Titan Biotech dividend yield is 0.28% based on the trailing twelve month period.
Does Titan Biotech pay a dividend?
Last year, Titan Biotech paid a total dividend of IN₹2.00, and it currently has a trailing dividend yield of 0.28%. We do not have any data on when Titan Biotech is to next pay dividends.
When does Titan Biotech next pay dividends?
We do not have data on when Titan Biotech is to next pay dividends. The historic dividend yield on Titan Biotech shares is currently 0.28%.
How do I buy Titan Biotech shares?
To buy shares in Titan Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Titan Biotech?
As of the previous close price of IN₹717.15, shares in Titan Biotech had a market capitalisation of IN₹5.93bn.
Where are Titan Biotech shares listed?
Here are the trading details for Titan Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524717
What kind of share is Titan Biotech?
Based on an overall assessment of its quality, value and momentum Titan Biotech is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Titan Biotech share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Titan Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Titan Biotech. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +22.07%.
As of the last closing price of IN₹717.15, shares in Titan Biotech were trading +30.47% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Titan Biotech PE Ratio?
The Titan Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹717.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Titan Biotech?
Titan Biotech's management team is headed by:
- Charanjit Singh - CCO
- Naresh Singla - MDR
- Suresh Singla - MDR
- Manju Singla - NED
- Rekha Dalmia - IND
- Rohit Jain - NID
- Ruchi Jain - NID
- Praveen Somani - NID